Association between NFKB1 -94 insertion/deletion ATTG polymorphism and risk of intracranial aneurysm

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 8, 2013, Pages 620-624

  Sima, Xiutian ^a   Xu, Jianguo ^a   Li, Jin ^a   You, Chao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INDEL MUTATION; INSERTION DELETION ATTG POLYMORPHISM; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; VERTEBRAL ARTERY; CLINICAL TRIAL; DNA RESPONSIVE ELEMENT; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK FACTOR;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INDEL MUTATION; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; RESPONSE ELEMENTS; RISK FACTORS;

EID: 84881130260     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0110     Document Type: Article

References (46)

1. Aoki T, Kataoka H, Ishibashi R, et al. (2009) Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 40:942-951.
2. Aoki T, Kataoka H, Morimoto M, et al. (2007a) Macrophagederived matrix metalloproteinase-2 and - 9 promote the progression of cerebral aneurysms in rats. Stroke 38:162-169.
3. Aoki T, Kataoka H, Shimamura M, et al. (2007b) NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation 116:2830-2840.
4. Aoki T, Nishimura M (2010) Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappa B as a putative target of medical therapy. Expert Opin Ther Targets 14:265-273.
5. Aoki T, Nishimura M (2011) The development and the use of experimental animal models to study the underlying mechanisms of CA formation. J Biomed Biotechnol 2011:535921.
6. Aoki T, Nishimura M, Matsuoka T, et al. (2011) PGE(2)-EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-kappa B. Br J Pharmacol 163:1237-1249.
7. Butt C, Sun S, Peddle L, et al. (2005) Association of nuclear factor- kappaB in psoriatic arthritis. J Rheumatol 32:1742-1744.
8. Cao Y, Zhao J, Wang S, et al. (2002) Monocyte chemoattractant protein-1 mRNA in human intracranial aneurysm walls. Zhonghua Yu Fang Yi Xue Za Zhi 36:519-521.
9. Chyatte D, Bruno G, Desai S, et al. (1999) Inflammation and intracranial aneurysms. Neurosurgery 45:1137-1146; discussion 46-47.
10. Clarke M (2008) Systematic review of reviews of risk factors for intracranial aneurysms. Neuroradiology 50:653-664.
11. Erdman S, Fox JG, Dangler CA, et al. (2001) Typhlocolitis in NFkappa B-deficient mice. J Immunol 166:1443-1447.
12. Fogelholm R, Hernesniemi J, Vapalahti M (1993) Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 24:1649-1654.
13. Frosen J, Piippo A, Paetau A, et al. (2004) Remodeling of saccular cerebral artery aneurysm wall is associated with rupture - Histological analysis of 24 unruptured and 42 ruptured cases. Stroke 35:2287-2293.
14. Frosen J, Piippo A, Paetau A, et al. (2006) Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery 58:534-541; discussion 41.
15. Fukuda S, Hashimoto N, Naritomi H, et al. (2000) Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 101:2532-2538.
16. Glas J, Torok HP, Tonenchi L, et al. (2006) Role of the NFKB1 - 94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm Bowel Dis 12:606-611.
17. Hashimoto N, Handa H, Nagata I, et al. (1980) Experimentally induced cerebral aneurysms in rats: Part V. Relation of hemodynamics in the circle of Willis to formation of aneurysms. Surg Neurol 13:41-45.
18. Hassler O (1961) Morphological studies on the large cerebral arteries, with reference to the aetiology of subarachnoid haemorrhage. Acta Psychiatr Scand Suppl 154:1-145.
19. Investigators ISoUIA (1998) Unruptured intracranial aneurysms - risk of rupture and risks of surgical intervention. N Engl J Med 339:1725-1733.
20. Jayaraman T, Berenstein V, Li XG, et al. (2005) Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 57:558-563.
21. Jin D, Sheng J, Yang X, et al. (2007) Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol 68 Suppl 2:S11-S16; discussion S6.
22. Juvela S (2011) Prevalence of and risk factors for intracranial aneurysms. Lancet Neurol 10:595-597.
23. Kanematsu Y, Kanematsu M, Kurihara C, et al. (2011) Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 42:173-178.
24. Karban AS, Okazaki T, Panhuysen CI, et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13:35-45.
25. Kataoka K, Taneda M, Asai T, et al. (1999) Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 30:1396-1401.
26. Kim TH, Stone MA, Rahman P, et al. (2005) Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea. J Rheumatol 32:1907-1910.
27. Krex D, Schackert HK, Schackert G (2001) Genesis of cerebral aneurysms - an update. Acta Neurochir (Wien) 143:429-448; discussion 48-49.
28. Kumar A, Takada Y, Boriek AM, et al. (2004) Nuclear factorkappaB: its role in health and disease. J Mol Med (Berl) 82: 434-448.
29. Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, et al. (2007) Association of NFKB1 - 94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun 8:532-538.
30. Le Beau MM, Ito C, Cogswell P, et al. (1992) Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively. Genomics 14:529-531.
31. Mirza MM, Fisher SA, Onnie C, et al. (2005) No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 54:1205-1206.
32. Mohan S, Mohan N, Sprague EA (1997) Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments. Am J Physiol 273:C572-C578.
33. Moriwaki T, Takagi Y, Sadamasa N, et al. (2006) Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke 37:900-905.
34. Nieuwkamp DJ, Setz LE, Algra A, et al. (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635-642.
35. Nuki Y, Tsou TL, Kurihara C, et al. (2009) Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension 54:1337-1344.
36. Orozco G, Sanchez E, Collado MD, et al. (2005) Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 65:183-186.
37. Sadamasa N, Nozaki K, Hashimoto N (2003) Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 34:2980-2984.
38. Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107:7-11.
39. Takagi Y, Ishikawa M, Nozaki K, et al. (2002) Increased expression of phosphorylated c-Jun amino-terminal kinase and phosphorylated c-Jun in human cerebral aneurysms: role of the c-Jun amino-terminal kinase/c-Jun pathway in apoptosis of vascular walls. Neurosurgery 51:997-1002; discussion 4.
40. Takeuchi S, Karino T (2010) Flow patterns and distributions of fluid velocity and wall shear stress in the human internal carotid and middle cerebral arteries. World Neurosurg 73:174- 185; discussion e27.
41. Verma IM, Stevenson JK, Schwarz EM, et al. (1995) Rel/Nfkappa- B/I-kappa-B family - intimate tales of association and dissociation. Genes Dev 9:2723-2735.
42. Virchow V (1847) Uber die akute Entzundung der Arterien. Virchows Arch Pathol Anat Histopathol 1:272-378.
43. Wermer MJ, van der Schaaf IC, Algra A, et al. (2007) Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated metaanalysis. Stroke 38:1404-1410.
44. Wiebers DO, Whisnant JP, Huston J, 3rd, et al. (2003) Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:103-110.
45. Yalcin B, Atakan N, Alli N. (2008) The functional role of nuclear factor kappa-kappaB1 - 94 ins/del ATTG promotor gene polymorphism in Behcet's disease: an exploratory study. Clin Exp Dermatol 33:629-633.
46. Zhou B, Rao L, Peng Y, et al. (2009). Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy. BMC Med Genet 10:47.